What Causes Diabetes: Types, Risk Factors, and Science
A fact-based guide to diabetes mellitus — the science behind Type 1, Type 2, and gestational diabetes, their causes, risk factors, and global impact.
Diabetes Mellitus: A Global Health Challenge
Diabetes mellitus is a group of chronic metabolic disorders characterized by persistently elevated blood glucose levels (hyperglycemia) resulting from defects in insulin secretion, insulin action, or both. According to the International Diabetes Federation (IDF), approximately 537 million adults aged 20–79 were living with diabetes in 2021, and this number is projected to reach 783 million by 2045. Diabetes was directly responsible for approximately 6.7 million deaths in 2021, making it one of the top 10 causes of death globally.
Understanding what causes diabetes — the interplay of genetics, autoimmunity, insulin resistance, and lifestyle factors — is essential for prevention and management. This article examines the science behind the major forms of diabetes and their risk factors.
How Blood Sugar Regulation Works
To understand diabetes, it is necessary to understand normal glucose homeostasis. After eating, carbohydrates are broken down into glucose, which enters the bloodstream. Rising blood glucose triggers the beta cells of the pancreatic islets of Langerhans to secrete insulin. Insulin acts as a key, binding to insulin receptors on cell surfaces and activating glucose transporter proteins (primarily GLUT4) that allow glucose to enter muscle, fat, and liver cells for energy or storage as glycogen.
When blood glucose drops (between meals or during exercise), alpha cells in the pancreas secrete glucagon, which stimulates the liver to break down glycogen into glucose (glycogenolysis) and produce new glucose from non-carbohydrate sources (gluconeogenesis), raising blood sugar back to normal.
Normal fasting blood glucose is 70–100 mg/dL. Diabetes is diagnosed when fasting glucose is ≥126 mg/dL, HbA1c is ≥6.5%, or a 2-hour oral glucose tolerance test result is ≥200 mg/dL.
Types of Diabetes
| Type | Cause | Onset | % of All Cases |
|---|---|---|---|
| Type 1 diabetes | Autoimmune destruction of pancreatic beta cells | Usually childhood/adolescence; can occur at any age | ~5–10% |
| Type 2 diabetes | Insulin resistance + progressive beta cell dysfunction | Usually adulthood; increasingly in children/adolescents | ~90–95% |
| Gestational diabetes | Insulin resistance induced by placental hormones during pregnancy | 2nd–3rd trimester of pregnancy | ~2–10% of pregnancies |
| LADA | Slow autoimmune beta cell destruction (features of both Type 1 and 2) | Adulthood (typically >30 years) | ~2–12% of "Type 2" diagnoses |
| MODY | Single-gene mutations affecting beta cell function | Usually before age 25 | ~1–5% |
Type 1 Diabetes: Autoimmune Beta Cell Destruction
Type 1 diabetes (T1D) is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreatic islets. By the time symptoms appear, approximately 80–90% of beta cells have been destroyed, resulting in absolute insulin deficiency.
Causes and Risk Factors
- Genetic susceptibility: The HLA (human leukocyte antigen) gene region on chromosome 6 accounts for approximately 40–50% of genetic risk. Specific HLA-DR and HLA-DQ alleles (particularly HLA-DR3/DR4) are strongly associated with T1D.
- Autoimmune mechanism: Autoreactive T cells infiltrate the islets (insulitis) and destroy beta cells. Autoantibodies — including anti-GAD65, anti-IA-2, anti-insulin, and anti-ZnT8 — are detectable months to years before clinical onset.
- Environmental triggers: Viral infections (particularly enteroviruses such as Coxsackievirus B), early childhood diet, and gut microbiome composition may trigger autoimmunity in genetically susceptible individuals.
- Family history: Risk is approximately 5% with an affected parent (higher with an affected father) and approximately 50% with an affected identical twin.
Type 2 Diabetes: Insulin Resistance and Beta Cell Failure
Type 2 diabetes (T2D) develops through a two-phase process: insulin resistance followed by progressive beta cell dysfunction.
Phase 1: Insulin Resistance
Target tissues — primarily muscle, liver, and adipose tissue — become less responsive to insulin. The pancreas compensates by producing more insulin (hyperinsulinemia), initially maintaining normal blood glucose levels. This compensated state can persist for years.
Phase 2: Beta Cell Failure
Over time, beta cells cannot sustain the elevated insulin output. They undergo dysfunction and apoptosis (cell death), likely driven by glucotoxicity (chronic high glucose), lipotoxicity (elevated free fatty acids), and amyloid deposition (islet amyloid polypeptide). Blood glucose rises progressively, first to prediabetes levels (fasting glucose 100–125 mg/dL or HbA1c 5.7–6.4%) and eventually to diabetic levels.
Risk Factors for Type 2 Diabetes
| Risk Factor | Impact | Evidence |
|---|---|---|
| Obesity (BMI ≥30) | Most significant modifiable risk factor; increases insulin resistance | ~80% of T2D patients are overweight or obese |
| Physical inactivity | Reduced glucose uptake by muscles; promotes insulin resistance | 150 min/week moderate exercise reduces risk ~58% (DPP trial) |
| Family history | Strong genetic component; polygenic inheritance | 40% risk with one parent affected; 70% with both |
| Ethnicity | Higher prevalence in certain populations | South Asian, African American, Hispanic, Native American populations at elevated risk |
| Age ≥45 years | Beta cell function declines with age; insulin sensitivity decreases | Risk increases progressively after age 45 |
| Visceral adiposity | Abdominal fat is metabolically active; releases inflammatory cytokines | Waist circumference >102 cm (men) or >88 cm (women) increases risk |
| Gestational diabetes history | Indicates underlying insulin resistance | 50% of women with GDM develop T2D within 5–10 years |
Gestational Diabetes
Gestational diabetes mellitus (GDM) occurs when placental hormones — including human placental lactogen, cortisol, and progesterone — create insulin resistance that exceeds the pancreas's ability to compensate. GDM typically develops during the second or third trimester and resolves after delivery, but it signals increased metabolic risk for both mother and child.
- Maternal risks: Preeclampsia, need for cesarean delivery, and substantially elevated lifetime risk of developing T2D
- Fetal/neonatal risks: Macrosomia (large birth weight >4 kg), neonatal hypoglycemia, respiratory distress, and increased childhood obesity and T2D risk
Complications of Diabetes
Chronic hyperglycemia damages blood vessels and nerves throughout the body:
- Microvascular complications: Diabetic retinopathy (leading cause of blindness in working-age adults), diabetic nephropathy (leading cause of end-stage kidney disease), and diabetic neuropathy (affecting up to 50% of patients)
- Macrovascular complications: Cardiovascular disease (2–4 times higher risk), stroke, and peripheral arterial disease
- Other complications: Diabetic foot ulcers (leading cause of non-traumatic limb amputation), increased infection susceptibility, and cognitive decline
Prevention and Management
| Strategy | Evidence | Application |
|---|---|---|
| Weight loss (5–7% body weight) | Reduces T2D incidence by 58% (Diabetes Prevention Program) | T2D prevention in high-risk individuals |
| Regular physical activity | 150 min/week moderate exercise improves insulin sensitivity | Both prevention and management |
| Metformin | First-line oral medication; reduces hepatic glucose production | T2D management; 31% risk reduction in DPP |
| Insulin therapy | Essential for T1D; may be needed for advanced T2D | All T1D patients; T2D when oral agents insufficient |
| HbA1c monitoring | Reflects 2–3 month average blood glucose; target <7% for most adults | Ongoing management for all diabetes types |
| Continuous glucose monitoring (CGM) | Real-time glucose data improves glycemic control and reduces hypoglycemia | T1D and insulin-treated T2D |
Disclaimer: This article is intended for educational purposes only and does not constitute medical advice. Diabetes is a serious medical condition requiring professional management. Always consult a qualified healthcare professional for diagnosis, treatment, and ongoing care.